THOUGHTSPOT Menopause Care: How Personalized Medicine Helps You Cope Better (But Challenges Remain)ByAndrea LaceyMay 23, 20240Comments
News The EC Grants Approval to Celltrion’s Omlyclo (Biosimilar, Xolair)ByDipanshu DixitMay 23, 20240Comments
News Celltrion’s CT-P39 (biosimilar, omalizumab) Receives the CHMP’s Recommendation for Marketing Authorization to Treat Multiple Indications ByDipanshu DixitMay 23, 20240Comments
VIEWPOINTS Increasing Accessibility: Jeffrey Lengyel from Thermo Fisher Scientific, in an Enlightening Conversation with PharmaShotsBySaurabh ChaubeyMay 22, 20240Comments
INSIGHTS+ Insights+: EMA Marketing Authorization of New Drugs in April 2024ByDipanshu DixitMay 21, 20240Comments
News Alvotech Collaborates with Dr. Reddy’s to Commercialize AVT03 (Biosimilar, Prolia & Xgeva) ByRidhi RastogiMay 21, 20240Comments
News Biocon’s Yesafili (Biosimilar, Eylea) Receives the US FDA’s Approval for Ophthalmology ByDipanshu DixitMay 21, 20240Comments
VIEWPOINTS Drug Discount Solutions: Gavin Magaha from Kalderos, in a Stimulating Conversation with PharmaShotsBySaurabh ChaubeyMay 20, 20240Comments
